With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analysing both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront of finding vaccines and cures for potentially deadly viral diseases.
Join our webinar to learn more about:
Head of consulting and customer success
William Mansfield is the head of consulting and customer success at LexisNexis® PatentSight®. He is responsible for the creation and delivery of PatentSight’s consulting projects. He works closely with numerous international and Fortune 500 companies to ensure effective deployment of patent analyses for business strategy, M&A due diligence and portfolio management.